Inventiva S.A. American Depository Shares IVA
i
Market datapartial · fetched 2026-11-11T14:51:11.722Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-11T14:51:00.397420422Z
FundamentalsAlpha Vantage · unavailable
Inventiva S.A. American Depository Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 2.72 | 567.7% | 47.4% | |||
| 25Δ | 3.15 | 554.0% | 42.7% | |||
| 30Δ | 8.27 | 501.5% | 123.1% | 3.57 | 540.3% | 38.1% |
| 35Δ | 7.00 | 467.7% | 92.3% | 3.99 | 526.7% | 33.4% |
| 40Δ | 6.27 | 452.1% | 75.7% | 4.41 | 513.0% | 28.8% |
| 45Δ | 5.55 | 436.5% | 59.0% | 4.83 | 499.3% | 24.1% |
| 50Δ | 4.91 | 429.9% | 45.3% | 5.40 | 496.1% | 20.7% |
| 55Δ | 4.54 | 450.7% | 40.5% | 6.06 | 499.9% | 18.1% |
| 60Δ | 4.17 | 471.4% | 35.7% | 6.73 | 503.6% | 15.6% |
| 65Δ | 3.80 | 492.2% | 30.8% | 7.39 | 507.4% | 13.0% |
| 70Δ | 3.43 | 512.9% | 26.0% | |||
| 75Δ | 3.07 | 533.7% | 21.2% | |||
| 80Δ | 2.70 | 554.4% | 16.3% | |||
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 2.72
- IV
- 567.7%
- B/E move
- 47.4%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 3.15
- IV
- 554.0%
- B/E move
- 42.7%
30Δ
- Pseudo strike
- 8.27
- IV
- 501.5%
- B/E move
- 123.1%
- Pseudo strike
- 3.57
- IV
- 540.3%
- B/E move
- 38.1%
35Δ
- Pseudo strike
- 7.00
- IV
- 467.7%
- B/E move
- 92.3%
- Pseudo strike
- 3.99
- IV
- 526.7%
- B/E move
- 33.4%
40Δ
- Pseudo strike
- 6.27
- IV
- 452.1%
- B/E move
- 75.7%
- Pseudo strike
- 4.41
- IV
- 513.0%
- B/E move
- 28.8%
45Δ
- Pseudo strike
- 5.55
- IV
- 436.5%
- B/E move
- 59.0%
- Pseudo strike
- 4.83
- IV
- 499.3%
- B/E move
- 24.1%
50Δ
- Pseudo strike
- 4.91
- IV
- 429.9%
- B/E move
- 45.3%
- Pseudo strike
- 5.40
- IV
- 496.1%
- B/E move
- 20.7%
55Δ
- Pseudo strike
- 4.54
- IV
- 450.7%
- B/E move
- 40.5%
- Pseudo strike
- 6.06
- IV
- 499.9%
- B/E move
- 18.1%
60Δ
- Pseudo strike
- 4.17
- IV
- 471.4%
- B/E move
- 35.7%
- Pseudo strike
- 6.73
- IV
- 503.6%
- B/E move
- 15.6%
65Δ
- Pseudo strike
- 3.80
- IV
- 492.2%
- B/E move
- 30.8%
- Pseudo strike
- 7.39
- IV
- 507.4%
- B/E move
- 13.0%
70Δ
- Pseudo strike
- 3.43
- IV
- 512.9%
- B/E move
- 26.0%
- Pseudo strike
- IV
- B/E move
75Δ
- Pseudo strike
- 3.07
- IV
- 533.7%
- B/E move
- 21.2%
- Pseudo strike
- IV
- B/E move
80Δ
- Pseudo strike
- 2.70
- IV
- 554.4%
- B/E move
- 16.3%
- Pseudo strike
- IV
- B/E move
Options history
No recorded observations
Biotechnology
IVVD
Adagio Therapeutics, Inc., a clinical-stage biopharmaceutical company, is focused on the discovery, development and commercialization of antibody-based solutions for infectious…
More →JANX
Janux Therapeutics, Inc., a biopharmaceutical company, develops therapies based on the patented Tumor Activated T Cell Engager (TRACTr) platform technology to treat cancer…
More →JAZZ
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and markets pharmaceutical products for various unmet medical needs in the United States, Europe, and…
More →JBIO
Jade Biosciences, Inc. is a biotechnology company that develops therapies for inflammation and immunology indications in patients living with autoimmune diseases. The company is…
More →JSPR
Description unavailable
More →KARD
Kardigan, Inc. is an innovative technology company specializing in advanced software solutions for retail and e-commerce industries. With a strong focus on enhancing customer…
More →